In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- ...

High-fidelity oligo synthesis was key for experimentally confirming AI-predicted DNA sequences linked to favorable gene expression changes controlling desired crop traits. Feeding a growing global ...

VIENNA--(BUSINESS WIRE)--Ribbon Bio GmbH, the DNA synthesis company, today announced the launch of MiroSynth™ DNA, its first commercial product designed to meet the growing demand for complex and ...

PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in ...

Researchers have built a synthetic-cell platform that can be chemically adjusted in real time, sidestepping a long-standing bottleneck in artificial cell design. The system, based on coacervate ...

Google's new AI tool can read DNA like a language, and see immediately if a word substitution will change the meaning of that sentence, the company says. — © AFP ...

Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...